Authors: Peter G. Middleton, Elisabeth J. Gade, Cristina Aguilera, Lucy MacKillop, Brenda M. Button, Courtney Coleman, Barbara Johnson, Charlotte Albrechtsen, Frank Edenborough, David Rigau, Peter G. Gibson, Vibeke Backer
Published: 2019-11-07
DOI: 10.1183/13993003.01208-2019
Source: Full article
This European Respiratory Society/Thoracic Society of Australia and New Zealand statement outlines a review of the literature and expert opinion concerning the management of reproduction and pregnancy in women with airways diseases: asthma, cystic fibrosis (CF) and non-CF bronchiectasis. Many women with these diseases are now living into reproductive age, with some developing moderate-to-severe impairment of lung function in early adulthood. The statement covers aspects of fertility, management during pregnancy, effects of drugs, issues during delivery and the post-partum period, and patients’ views about family planning, pregnancy and parenthood. The statement summarises current knowledge and proposes topics for future research, but does not make specific clinical recommendations.